1. Home
  2. WEST vs CGEM Comparison

WEST vs CGEM Comparison

Compare WEST & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westrock Coffee Company

WEST

Westrock Coffee Company

HOLD

Current Price

$7.96

Market Cap

773.6M

ML Signal

HOLD

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

HOLD

Current Price

$15.56

Market Cap

904.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WEST
CGEM
Founded
2009
2016
Country
United States
United States
Employees
1393
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
773.6M
904.7M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
WEST
CGEM
Price
$7.96
$15.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
8
Target Price
$7.00
$30.13
AVG Volume (30 Days)
1.0M
1.0M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$11.27
N/A
Revenue Next Year
$10.66
$5.20
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.59
$5.68
52 Week High
$8.98
$16.74

Technical Indicators

Market Signals
Indicator
WEST
CGEM
Relative Strength Index (RSI) 57.74 54.75
Support Level $7.73 $11.92
Resistance Level $8.98 $16.21
Average True Range (ATR) 0.48 0.98
MACD -0.12 0.09
Stochastic Oscillator 19.23 65.53

Price Performance

Historical Comparison
WEST
CGEM

About WEST Westrock Coffee Company

Westrock Coffee Co is an integrated coffee, tea, flavors, extracts, and ingredients solutions provider mainly in the United States. Additionally, it offers coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to retail, foodservice, restaurant, convenience store, travel center, non-commercial account, and hospitality industries around the world. The company's reportable segments are: Beverage Solutions and Sustainable Sourcing and Traceability. It generates maximum revenue from the Beverage Solutions segment, which offers beverage solutions, including coffee, tea, flavors, extracts, and ingredients. Geographically, the company generates maximum revenue from its business in the United States and the rest from other countries.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a clinical-stage biopharmaceutical company developing therapies for autoimmune diseases and cancer. Its development pipeline comprises the following drug candidates: CLN-978, a CD19xCD3 bispecific T cell engager that is being developed for autoimmune diseases; CLN-049, a FLT3xCD3 bispecific T cell engager being evaluated in an ongoing clinical trial in patients with relapsed/refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS); Velinotamig, a BCMAxCD3 bispecific T cell engager being developed to counter autoimmune diseases; and Zipalertinib, being developed as a treatment for non-small cell lung cancer. Additionally, the company is developing several preclinical programs in autoimmune diseases and oncology.

Share on Social Networks: